Bio Green Med Solution (BGMS) EPS (Basic) Growth (3y) (2013 - 2026)
Powered by 
Analysis
Bio Green Med Solution (BGMS) EPS (Basic) Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.65 Bn | 133.79 Bn | 2.84 Bn | 6.85% |
| 2 | Regeneron Pharmaceuticals | 87.58 Bn | 79.59 Bn | 3.93 Bn | 11.71% |
| 3 | Argenx Se | 64.93 Bn | 59.74 Bn | 1.37 Bn | 86.03% |
| 4 | Moderna | 58.15 Bn | 53.02 Bn | 52.00 Mn | 18.44% |
| 5 | Revolution Medicines | 44.29 Bn | 44.29 Bn | - | - |
| 6 | BeOne Medicines | 40.55 Bn | 35.45 Bn | 1.53 Bn | 37.21% |
| 7 | Alnylam Pharmaceuticals | 35.00 Bn | 31.69 Bn | 992.69 Mn | 36.73% |
| 8 | Royalty Pharma | 28.25 Bn | 27.42 Bn | - | -38.31% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 67.51% |
| 10 | Bio Green Med Solution | 5.50 Mn | 1.71 Mn | 79,000.00 | 96.36% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 96.36% |
| Mar 31, 2026 | 97.13% |
| Dec 31, 2025 | 87.51% |
| Sep 30, 2025 | 90.52% |
| Jun 30, 2025 | 91.57% |
| Mar 31, 2025 | 94.71% |
| Dec 31, 2024 | -26.77% |
| Sep 30, 2024 | 74.25% |
| Jun 30, 2024 | 23.07% |
| Mar 31, 2024 | 22.55% |
| Dec 31, 2023 | 25.93% |
| Sep 30, 2023 | -2.52% |
| Jun 30, 2023 | 8.69% |
| Mar 31, 2023 | 31.87% |
| Dec 31, 2022 | 32.14% |
| Sep 30, 2022 | 42.72% |
| Jun 30, 2022 | 40.17% |
| Mar 31, 2022 | 46.91% |
| Dec 31, 2021 | 33.57% |
| Sep 30, 2021 | 41.30% |